1 |
Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006;164:263-271. https://doi.org/10.1093/aje/kwj173
DOI
|
2 |
Kiuchi MG, Mion D Jr. Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope? Kidney Res Clin Pract. 2016;35:3-9. https://doi.org/10.1016/j.krcp.2015.11.003
DOI
|
3 |
Yoon H, Lee JH. Relationship between the estimated glomerular filtration rate and the urine microalbumin/creatinine ratio and ferritin in Korean adults. Korean J Clin Lab Sci. 2019;51:145-154. https://doi.org/10.15324/kjcls.2019.51.2.145
DOI
|
4 |
Vejakama P, Ingsathit A, McKay GJ, Maxwell AP, McEvoy M, Attia J, et al. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients. BMC Nephrol. 2017;18:342. https://doi.org/10.1186/s12882-017-0753-9.
DOI
|
5 |
Lin YP. Albuminuria in hypertension. Hypertens Res. 2013;36:762-764. https://doi.org/10.1038/hr.2013.76
DOI
|
6 |
Renna NF, de Las Heras N, Miatello RM. Pathophysiology of vascular remodeling in hypertension. Int J Hypertens. 2013;2013:808353. https://doi.org/10.1155/2013/808353
DOI
|
7 |
Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol. 2006;17:2106-2111. https://doi.org/10.1681/ASN.2005121288
DOI
|
8 |
Ruiz-Hurtado G, Ruilope LM, de la Sierra A, Sarafidis P, de la Cruz JJ, Gorostidi M, et al. Association between high and very high albuminuria and nighttime blood pressure: influence of diabetes and chronic kidney disease. Diabetes Care. 2016;39:1729-1737. https://doi.org/10.2337/dc16-0748.
DOI
|
9 |
Lee HF, See LC, Chan YH, Yeh YH, Wu LS, Liu JR, et al. End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese nationwide cohort study. Intern Med J. 2018;48:1123-1132. https://doi.org/10.1111/imj.13971
DOI
|
10 |
Wang K, Hu J, Luo T, Wang Y, Yang S, Qing H, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality and renal outcomes in patients with diabetes and albuminuria: a systematic review and meta-analysis. Kidney Blood Press Res. 2018;43:768-779. https://doi.org/10.1159/000489913
DOI
|
11 |
Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285:2719-2728. https://doi.org/10.1001/jama.285.21.2719
DOI
|
12 |
Zheng CM, Wang JY, Chen TT, Wu YC, Wu YL, Lin HT, et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population. Sci Rep. 2019;9:2694. https://doi.org/10.1038/s41598-019-38991-z
DOI
|
13 |
Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol. 2014;3:99-104. https://doi.org/10.12860/jnp.2014.19
DOI
|
14 |
Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY, et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study. Circulation. 2011;123:2946-2953. https://doi.org/10.1161/CIRCULATIONAHA.111.020982
DOI
|
15 |
Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-426. https://doi.org/10.1001/jama.286.4.421
DOI
|
16 |
Nayor M, Larson MG, Wang N, Santhanakrishnan R, Lee DS, Tsao CW, et al. The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail. 2017;19:615-623. https://doi.org/10.1002/ejhf.778
DOI
|
17 |
Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745-753.
DOI
|
18 |
Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lance.t 2008;371:2173-2182. https://doi.org/10.1016/S0140-6736(08)60952-6
DOI
|
19 |
Guh JY. Proteinuria versus albuminuria in chronic kidney disease. Nephrology (Carlton). 2010;15(Suppl 2):53-56. https://doi.org/10.1111/j.1440-1797.2010.01314.x
DOI
|
20 |
Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969-975. https://doi.org/10.1161/CIRCULATIONAHA.105.538132
DOI
|
21 |
Viazzi F, Leoncini G, Conti N, Tomolillo C, Giachero G, Vercelli M, et al. Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study. Clin J Am Soc Nephrol. 2010;5:1099-1106. https://doi.org/10.2215/CJN.07271009
DOI
|
22 |
van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79:1341-1352. https://doi.org/10.1038/ki.2010.536
DOI
|
23 |
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247-259. https://doi.org/10.1038/sj.ki.5002343
DOI
|
24 |
Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275-2284. https://doi.org/10.1681/ASN.2005121273
DOI
|
25 |
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047. https://doi.org/10.1001/jama.298.17.2038
DOI
|
26 |
National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):1-266.
DOI
|
27 |
Bakris GL, Ritz E. World Kidney Day Steering Committee: The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. J Clin Hypertens (Greenwich). 2009;11:144-147. https://doi.org/10.1097/HJH.0b013e328327706a
DOI
|
28 |
Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001;161:1207-1216. https://doi.org/10.1001/archinte.161.9.1207
DOI
|
29 |
Ahn HJ, Moon DS, Kang DY, Lee JI, Kim DY, Kim JH, et al. Urinary albumin excretion reflects cardiovascular risk in postmenopausal women without diabetes: The 2011 to 2013 Korean National Health and Nutrition Examination Survey. Endocrinol Metab (Seoul). 2016;31:537-546. https://doi.org/10.3803/EnM.2016.31.4.537
DOI
|
30 |
Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291-297. https://doi.org/10.1016/s0002-9343(03)00366-8
DOI
|
31 |
American Diabetes Association. 9. Cardiovascular disease and risk management. Diabetes Care. 2017;40(Suppl 1):75-87. https://doi.org/10.2337/dc17-S012
DOI
|
32 |
Gee MY, Yoon H. The association of uine mcroalbumin and pulse pressure in Korean adults. Korean J Clin Lab Sci. 2016;48:183-187. https://doi.org/10.15324/kjcls.2016.48.3.183
DOI
|
33 |
Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713-735. https://doi.org/10.1053/j.ajkd.2014.01.416
DOI
|
34 |
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28. https://doi.org/10.1038/ki.2010.483
DOI
|
35 |
Chen J, Wildman RP, Gu D, Kusek JW, Spruill M, Reynolds K, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005;68:2837-2845. https://doi.org/10.1111/j.1523-1755.2005.00757.x
DOI
|
36 |
Levey AS, Stevens LA. Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55:622-627. https://doi.org/10.1053/j.ajkd.2010.02.337
DOI
|
37 |
Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117. https://doi.org/10.1186/1471-2458-8-117
DOI
|